The DiabCare Asia 2008 study – outcomes on control and complications of type 2 diabetic patients in Indonesia

Medical Journal of Indonesia

Volumn 19, Issue 4, 2010, Pages 235-244

  Soewondo, Pradana ^a   Soegondo, Sidartawan ^a   Suastika, Ketut ^b   Pranoto, Agung ^c   Soeatmadji, Djoko W ^d   Tjokroprawiro, Askandar ^c  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^b UDAYANA UNIVERSITY   (Indonesia)

^c AIRLANGGA UNIVERSITY   (Indonesia)

^d Saiful Anwar General Hospital   (Indonesia)

Author keywords

DiabCare; DiabCare Indonesia; Diabetes complications; Dyslipidaemia; Glycaemic control; Hypertension

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANGIOPLASTY; ARTICLE; CATARACT; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; FEMALE; FOOT ULCER; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INDONESIA; LIPID ANALYSIS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RETINOPATHY; RISK FACTOR;

EID: 85008970156     PISSN: 08531773     EISSN: 22528083     Source Type: Journal    
DOI: 10.13181/mji.v19i4.412     Document Type: Article

References (22)

1. Sutanegara D, Darmono, Budhiaartha AAG. The epidemiology, and management of diabetes mellitus in Indonesia. Diabetes Research and Clinical Practice. 2000;50: S9-S16
2. IDF Diabetes Atlas, 4th ed. ©International Diabetes Federation, 2009.
3. Mihardja L, Delima, Siswoyo H, Ghani L, Soegondo S. Prevalence and Determinants of Diabetes Mellitus and Impaired Glucose Tolerance in Indonesia (A Part of Basic Health Research/Riskesdas). Acta Med Indones-Indones J Intern Med. 2009:41:169-74.
4. RISKESDAS SUMATERA BARAT 2007, Basic Health Research of West Sumatera Province, Indonesian Ministry of Health, Health Research and Development Body, 2008.
5. RISKESDAS BALI 2007, Basic Health Research of Bali Province 2007, Indonesian Ministry of Health, Health Research and Development Body, 2008.
6. Perkeni. Konsensus Pengelolaan Diabetes di Indonesia; 2006.
7. Harbuwono DK, Purnamasari D, Soegondo S, Edi TJ, Em YB, Soebardi S, et al. Prevalence of Diabetes Mellitus in Jakarta. AASD Poster Presentation; II-P-41. 2009 May 22; Osaka, Japan 8. World Health Organization: Regional Office for Europe (1998) Well-Being measures in primary health care: The DiabCare Project. Consensus meeting, Stockholm
8. Skovlund SE, Peyrot M, on behalf of the DAWN International Advisory Panel. The Diabetes Attitudes, Wishes, and Needs (DAWN) Program: A New Approach to Improving Outcomes of Diabetes Care. 2005; 18:136-42
9. Asia-Pacific Type 2 Diabetes Policy Group. Type 2 Diabetes-Practical Targets and Treatments, 2nd edn. Sydney, Australia: Health Communications Australia Pty, 1999.
10. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2000;23:S32-S42.
11. Ryde L, Standl E, Bartnik M, Van den Berghe G, Betteridge J et al, The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J. 2007;28:88-136.
12. IDF Global Guideline for Type 2 Diabetes, 2005
13. WHO expert consultation. Lancet. 2004;363:157-63
14. Mafauzy M on Behalf of the Diabcare-Asia 2003 Study Group. An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies. Curr Med Res Opin. 2008; 24: 507-14.
15. Data on file, Novo Nordisk, 2003.
16. The QuED Study Group. The relationship between physicians’self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group - quality of care and outcomes in type 2 diabetes. Diabetes Care.2001;24:423-9
17. Wallace TM, and Matthews DR. Tha assessment of insulin resistance in man. Diabet Med. 2002; 19: 527-534.
18. NIH Publication No. 08-6286; May 2008
19. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Predictors of Stroke in Middle-Aged Patients With Non-Insulin-Dependent Diabetes. Stroke. 1996; 27: 63-8.
20. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
21. Ashwell S, Bradley C, Stephens JW, Witthaus E and Home P. Treatment satisfaction and quality of life with insulin glargine and insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with Type 1 diabetes. Diabetes care 2008;31:1112-7
22. Turner RC, Cull CA, Frighi V et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999; 281:2005-12.